Evaluation of oxidative stress as a cause for idiopathic male infertility and the role of Addyzoa in its treatment

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2009/091/000551

Enrollment

Registered

2009-07-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Addyzoa capsules: 2 BD for 3 months Control Intervention1: Placebo: 2 BD for 3 months

Eligibility

Inclusion criteria

Inclusion criteria: Infertile male, normal semen volume with either oligospermia (sperm density between 5 and 20 million/mL) or asthenospermia or teratospermia by WHO criteria

Exclusion criteria

Exclusion criteria: Identifiable cause for semen abnormality (varicocele, cryptorchidism, orchitis, radiation, chemotherapy, recent febrile illness, hormonal abnormality etc)

Design outcomes

Primary

Measure	Time frame
Improvement in semen parametersTimepoint: 3 months and 6 months	—

Secondary

Measure	Time frame
PregnancyTimepoint: Upto 12 months	—

Countries

India

Contacts

Public ContactDr Rajeev Kumar

rajeev02@gmail.com01126594884

Outcome results